Waystar (WAY) Set to Post Earnings on Monday

Waystar (NASDAQ:WAY) will likely be posting its Q3 2026 results after the market closes on Monday, November 2nd. Analysts expect Waystar to post earnings of $0.4072 per share and revenue of $323.42 million for the quarter. Investors may review the information on the company’s upcoming Q3 2026 earnings overview page for the latest details on the call scheduled for Monday, November 2, 2026 at 4:30 PM ET.

Waystar (NASDAQ:WAY) last announced its earnings results on Wednesday, July 29th. The company reported $0.43 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.40 by $0.03. The business had revenue of $319.67 million for the quarter, compared to analyst estimates of $316.21 million. Waystar had a net margin of 11.18% and a return on equity of 7.03%. The company’s revenue for the quarter was up 18.1% compared to the same quarter last year. During the same quarter last year, the business earned $0.36 earnings per share. On average, analysts expect Waystar to post $1.47 EPS for the current fiscal year and $1.68 EPS for the next fiscal year.

Waystar Price Performance

WAY stock opened at $28.85 on Monday. The stock has a market capitalization of $5.53 billion, a P/E ratio of 41.21, a P/E/G ratio of 1.12 and a beta of 0.18. The firm has a 50-day simple moving average of $25.80 and a 200-day simple moving average of $23.10. The company has a quick ratio of 1.85, a current ratio of 1.85 and a debt-to-equity ratio of 0.36. Waystar has a 52 week low of $17.26 and a 52 week high of $40.35.

Wall Street Analysts Forecast Growth

A number of research analysts recently weighed in on the stock. Wells Fargo & Company decreased their price target on shares of Waystar from $36.00 to $33.00 and set an “overweight” rating on the stock in a research note on Thursday, July 30th. Wolfe Research upgraded Waystar to an “outperform” rating in a research note on Thursday, August 13th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and set a $39.00 target price on shares of Waystar in a report on Friday, July 31st. Morgan Stanley reissued an “equal weight” rating and set a $28.00 target price on shares of Waystar in a report on Wednesday, September 16th. Finally, Canaccord Genuity Group raised their target price on Waystar from $30.00 to $33.00 and gave the company a “buy” rating in a research report on Monday, August 31st. Two equities research analysts have rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $34.90.

Insider Activity

In other news, CEO Matthew Hawkins sold 82,500 shares of the company’s stock in a transaction on Tuesday, October 6th. The shares were sold at an average price of $26.23, for a total transaction of $2,163,975.00. Following the completion of the sale, the chief executive officer owned 1,804,794 shares of the company’s stock, valued at $47,339,746.62. This represents a 4.37% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 247,500 shares of company stock worth $6,370,499 over the last ninety days. 3.50% of the stock is owned by corporate insiders.

Waystar Company Profile

Waystar Holding Corp. is a healthcare technology company that provides cloud-based software designed to simplify administrative and financial processes across the healthcare industry. Its platform connects healthcare providers, health plans and patients, helping organizations manage revenue cycle operations and improve the flow of information and payments.

The company’s products and services include electronic claims management, eligibility and benefits verification, prior authorization, payment integrity, denial management, patient estimates and payments, billing automation, and healthcare analytics.